Sign Up for a Free Account
  • Updated 10.21.2020
  • Released 01.17.1994
  • Expires For CME 10.21.2023

Ciguatera

Introduction

Overview

Ciguatoxin, which was first isolated from a dinoflagellate from the Gambier Islands (a small group of islands, remnants of a caldera, in French Polynesia in the Pacific Ocean) and termed Gambierdiscus toxicus, is the most common nonbacterial food toxin related to seafood ingestion in the United States, Canada, and more recently, Europe. Ciguatoxin represents a number of lipid-soluble polyethers that are acid and heat stable; tasteless, colorless, and odorless; and have a number of pharmacologic effects. The clinical syndrome, termed “ciguatera,” is a serious, although rarely lethal, human food toxicity related to the consumption of tropical reef fish. Because fish is eaten in such abundance and distributed throughout the world, ciguatera can occur most anywhere and should be familiar to treating physicians. Soon clinicians may be able to directly test for ciguatoxins in patients to verify that they have been exposed to ciguatoxin, as opposed to relying solely on the clinical presentation.

Key points

• Ciguatera fish poisoning is a prevalent environmental toxic exposure found, for the most part, in tropical areas.

• Patients may be diagnosed in non-tropical areas if there is a history of travel in endemic areas or of eating tropical reef fish shipped to nonendemic areas.

• Chronic ciguatera symptoms are prevalent after acute exposure and can be exacerbated by foods containing alcohol and serotonin.

• Inverted sensory symptoms ("hot-cold") are common in ciguatera fish poisoning.

Historical note and terminology

Ciguatera poisoning is a serious, though rarely fatal, condition related to the consumption of tropical reef fish. Ciguatoxins are odorless, tasteless, and colorless neurotoxins that accumulate in many tissues of the fish, including the muscles, head, viscera, and roe. Ciguatoxins retain toxicity despite cooking and freezing (73).

A naming system has been proposed for the various ciguatoxins. CTX is used to indicate toxins that accumulate in fish to levels likely to cause ciguatera poisoning in humans. A letter code indicates the ocean or sea of origin of toxic fish (eg, Pacific Ocean is P-CTX) and a number code indicates the chronological order of reporting of the specific toxin (eg, P-CTX-1) (137).

One of the first recorded outbreaks of ciguatera poisoning occurred in 1774 on His Majesty’s Ship Resolution during Captain James Cook’s (1728-1779) second voyage to the Pacific (36).

British explorer Captain James Cook (1728-1779)
One of the first clear descriptions of ciguatera poisoning was from Cook’s second expedition. Oil-on-canvas portrait (1775-76) of British explorer Captain James Cook (1728-1779) by Nathaniel Dance-Holland (1735-1811). From the Nat...

On July 23, 1774, off of Malicolo island in the New Hebrides island group in the South Pacific (now the nation of Vanuatu), the ship’s surgeon William Anderson (1750-1778) recorded a clear account of ciguatera poisoning (01).

Clinical manifestations

Presentation and course

• Ciguatera affects multiple organ systems and may have gastrointestinal, neurologic, cardiovascular, dermatological, genitourinary, and emotional components.

• Neurologic manifestations affect more than 75% of cases.

• Neurologic manifestations usually follow the development of gastrointestinal symptoms.

• Neurologic symptoms can be protracted, sometimes lasting many months.

• Neurologic symptoms can include various sensory complaints, including numbness and dysesthesias of the extremities; pruritus; temperature reversal; cold allodynia; toothache; circumoral paresthesia; and burning mouth syndrome.

• Headaches, dizziness/vertigo, malaise/profound fatigue, circumoral tingling, dysgeusia (eg, metallic taste), dry mouth, pain or tingling in the extremities, and a "loose," sensation of the teeth are common complaints.

Ciguatera affects multiple organ systems and may have gastrointestinal, neurologic, cardiovascular, dermatological, genitourinary, and emotional components (37; 20). Onset of symptoms is usually within 15 minutes to 72 hours (most within 12 hours) of the ingestion of contaminated fish (07). Acute illness can be prolonged and the resulting neurologic symptoms can last months, with variable asymptomatic and symptomatic periods (28; 32; 33; 37; 30).

Gastrointestinal. Gastrointestinal symptoms are often the most frequent and earliest manifestations, affecting more than 90% of cases (20). Gastrointestinal symptoms include hypersalivation, abdominal cramps and pain, nausea, intense vomiting, and watery diarrhea. The symptoms generally resolve within one to two days (33).

Neurologic. Neurologic manifestations affect more than 75% of cases (20). Neurologic manifestations usually follow the development of gastrointestinal symptoms, suggesting that the neurologic manifestations may be due to a different physiologic process, such as neuronal or Schwann cell swelling through prolonged activation of sodium channels (02). Neurologic symptoms can be protracted, sometimes lasting many months (33).

Neurologic symptoms can include various sensory complaints, including numbness and dysesthesias (eg, prickling and burning sensations) of the extremities; pruritus (either generalized or affecting preferentially the palms and soles); temperature reversal (eg, where cold objects feel hot, or occasionally vice versa: "hot-cold inversion," "temperature reversal," "sensory inversion"); cold allodynia (ie, pain from mildly cold skin temperatures that would not generally be considered painful); toothache; circumoral paresthesia; and burning mouth syndrome (63; 07; 147; 11; 47; 20). The inverted sensory phenomenon is considered by some to be pathognomonic of involvement with marine toxins (09), although it has also been reported rarely in diabetic and uremic polyneuropathies (146). The Lhermitte phenomenon can occur with ciguatera poisoning (71), and hyperintense signal on T2-weighted sequences in the cervical cord has been reported with ciguatera poisoning (139).

Headaches, dizziness/vertigo, malaise/profound fatigue, circumoral tingling, dysgeusia (eg, metallic taste), dry mouth, pain or tingling in the extremities, and a "loose," sensation of the teeth are common complaints. Cranial nerve abnormalities may also include ptosis, miosis, trismus, various oculomotor and lower cranial nerve palsies, spontaneous downbeat and perverted head-shaking nystagmus, impaired smooth pursuit, visual fixation suppression failure during the bithermal caloric test, and aphonia (95). Other central nervous system manifestations may include opisthotonus, meningismus (ie, signs of meningeal irritation without meningitis), ataxia, and rarely intractable seizures (43). Neuromuscular abnormalities may include hyporeflexia/areflexia, stocking-glove hypesthesia or numbness, carpopedal spasm, myalgias, low back pain, muscle stiffness or spasm, fasciculations, and elevated CPK levels (139). Rarely, the patient may proceed to develop peripheral flaccid paralysis, respiratory muscle paralysis with respiratory failure, generalized seizures, stupor, and death.

Cardiovascular. Cardiovascular manifestations are noted in approximately 40% of cases (20). Cardiovascular manifestations most often involve bradycardia or hypotension but can include hypotension, hypertension, bradycardia, tachycardia, other arrhythmias, heart block, pulmonary edema, and congestive heart failure (07; 34; 32; 03; 20). In a study of 124 cases of ciguatera intoxication from French Polynesia, cardiovascular symptoms were the primary criteria of severity, with bradycardia and hypotension documented in 75% and 43%, respectively (55).

Dermatologic. The patient may develop a rash, which if present is usually diffuse, nonraised, confluent, and erythematous. Loss of hair and nails has been reported.

Genitourinary. Genitourinary signs include the following: painful urination; pain in the perineum, penis, or vagina; and pain in the penis during erection, which may be intensified during ejaculation (124). Cases have been reported of dyspareunia in unaffected women following ejaculation by their male partners, suggesting the possibility of sexual transfer of the toxin, although this has not been proven (79; 77; 27). The toxin can cross the placental barrier causing hypoactivity or shivering movements of the fetus that can be detected by sonography, and also similarly causing transient hypoactivity of the newborn. Ciguatoxin can be secreted in the breast milk causing hypersensitivity of the nipples that interferes with breast feeding, as well as diarrhea in the infant (Blythe and deSylva 1990).

Emotional. The patient may be emotionally depressed, hyperexcitable, anxious, nervous, giddy, apprehensive, restless, and agitated. Hysteria, delirium, hallucinations, and irrational behavior may occur (52). The varied and often inexplicable symptoms of ciguatera have been postulated in some cases to be related to somatization (140) but this is unlikely to explain many cases, even with unusual complaints, given the consistency of many of the reports of the affected individuals in different times and locales.

Hypothermia. A high frequency (approximately 60%) of hypothermia (ie, body temperature lower than 36.5 °C) was reported in one study (20).

Prognosis and complications

The prognosis of ciguatera poisoning is generally good, with symptoms typically subsiding within three to six weeks. However, the outcome apparently depends on the dose of toxin or toxins initially ingested, individual susceptibility, and whether sensitization has occurred. Once intoxication has occurred, the consumption of fish and alcohol may aggravate the condition, and should be eliminated from the diet, at least initially.

Chronic ciguatera. Chronic ciguatera is marked by disproportionate disability and nonspecific refractory symptoms such as fatigue, cognitive deficits, and pain, and has many similarities to chronic Lyme disease. After the acute phase of ciguatera, many bothersome symptoms may linger for months to years, including pruritus after alcohol consumption, dysesthesias, myalgias, arthralgias, sensitivity to cold, marked fatigue, malaise, and depression (09; 91; 61; 126; 105; 46; 85; 35). Ciguatera is a consideration in the differential diagnosis of chronic fatigue syndrome (107).

The disease is vastly underdiagnosed; diagnosis is made almost entirely by history, and usually in retrospect. There are few physical findings, none of which are diagnostic.

Any combination of gastrointestinal, neurologic, cardiovascular, dermatological, genitourinary, and emotional symptoms should arouse the clinical suspicion to inquire whether fish has been ingested. The initial gastrointestinal phase may be the only manifestation, and similarly isolated neurologic involvement may occur. Occasionally, a patient may present with only the inverted sensory phenomenon or with pruritus after alcohol and have no other symptoms. Reexposure may cause a significant worsening of symptoms (57).

Clinical vignette

An 18-year-old man suddenly developed painful dysesthesias while living in Hong Kong. He recalled no prior illnesses, other than some gastrointestinal distress and abdominal pain. The dysesthesias in his hands and feet waxed and waned, but were exacerbated by eating certain foods (eg, chicken, fish, and bouillabaisse) and drinking alcohol. He had no weakness. The patient’s neurologic exam was normal, except for some minimal sensory loss to vibration in his feet.

Nerve conduction velocity studies demonstrated a polyneuropathy involving both the hands and feet. The F waves were mildly delayed in his lower extremities, and his distal sensory and motor latencies were mildly delayed with relatively intact amplitudes. EMG showed some chronic denervation, suggesting some prior axonal involvement.

The patient's syndrome was compatible with a CTX-induced neuropathy. The ingestion of fish and alcohol is well known to exacerbate CTX neuropathy.

Biological basis

• Ciguatera poisoning is contracted by eating any of a large number of species of fish that have been reported to contain ciguatoxins, including most of the common shallow-water oceanic game fish and many of the smaller colorful reef dwellers.

• Although it has long been assumed that larger fish within a given species are more likely to contain a significant amount of toxin, empiric studies have not supported this.

• Ciguatoxins generally produce channelopathies affecting particularly voltage-sensitive sodium channels, but also calcium and potassium channels in some cases.

• Significant slowing of sensory and motor nerve conduction velocities and F-wave latencies with prolongation of the absolute refractory and supernormal periods has been demonstrated in ciguatera poisoning.

• Ciguatera sensitization occurs when people previously intoxicated with ciguatoxin suffer a recurrence of typical ciguatera symptoms after ingesting fish that do not cause symptoms in ciguatoxin-naive individuals.

Etiology and pathogenesis

The disease is contracted by eating any of a large number of species of fish that have been reported to contain ciguatoxins. These include most of the common shallow-water oceanic game fish and many of the smaller colorful reef dwellers. Common offenders include barracuda, snapper, jacks, grouper, Humphead wrasse, lionfish (including invasive Indo-Pacific lionfish in the western Atlantic Ocean), hogfish, kingfish, parrotfish, surgeonfish, rock hind, triggerfish, bigeye trevally, moray eel, and certain sharks (60; 07; 121; 28; 29; 118; 32; 33; 50; 31; 73; 128).

Toxin-bearing fish appear healthy and are apparently not adversely affected by the toxin. The toxic substance, a lipid-soluble polyether, is acid and heat stable, tasteless, colorless, odorless, and not removed by any known cleaning method; nor is it inactivated by storage conditions, cooking, freezing, salting, drying, smoking, marinating, or gastric juices.

Although it has long been assumed that larger fish within a given species are more likely to contain a significant amount of toxin, empiric studies have not supported this (54); because no relationship between the proportion of toxic fish within a family and the relative total length of individual fish was observed, fish size cannot be used as a reliable predictor of fish toxicity (54). Deep-water fish (especially below 50 fathoms) tend to be safer, but exceptions have occurred. Cold water fish outside of the tropical areas are generally free of the problem (eg, flounder, cod, haddock, halibut, perch, scrod, sole, salmon), as are shellfish, including lobster and crab, although a case was reported from eating farm-raised salmon (45). The latter may be related to toxin-laden fishmeal, as even livestock have been contaminated through exposure to fishmeal.

Ciguatera can be the clinical consequence of ingestion of multiple toxins found in flagellate protists, in particular benthic dinoflagellates (ie, dinoflagellates occupying the ecological region at the lowest level of a body of water). Ciguatoxins are a class of toxic, high-molecular-weight, polycyclic polyethers. Several have been identified, including CTX-1, CTX-2, CTX-3, CTX4, scaritoxin (a mixture of CTX-4A and CTX-4B), maitotoxin, (named from the ciguateric fish Ctenochaetus striatus—called "maito" in Tahiti), palytoxin, and okadaic acid (which can be involved in both diarrheic shellfish poisoning and ciguatera) (74; 132; 144).

A ciguatoxin was first isolated from Gambierdiscus toxicus, a dinoflagellate from the Gambier Islands (a small group of islands, remnants of a caldera, in French Polynesia in the Pacific Ocean) (08). Several additional dinoflagellates have since been demonstrated to harbor the toxins, some more toxic than G toxicus (133). These unicellular flagellated organisms can be found on bottom algae in tropical areas where herbivorous bottom-feeding fish scavenge for food. The same fish are later ingested by carnivorous fish, which may acquire high concentrations of ciguatoxin. Ciguatoxins can also accumulate in sea urchins and gastropods, which can produce ciguatera poisoning when they are eaten by indigenous populations of Pacific islands (40; 39; 56).

Initially considered to be anticholinesterases, ciguatoxins instead generally produce channelopathies affecting particularly voltage-sensitive sodium channels, but also in some cases calcium (eg, maitotoxin) and potassium channels (42; 119; 69). Patch-clamping experiments demonstrated that CTX-1 increases the neuronal excitability by shifting the voltage of activation of tetrodotoxin-sensitive Na+ channels to more negative potentials (64). Pacific-CTX-1 (P-CTX-1) acts on tetrodotoxin-resistant Na+ channels by increasing the rate of recovery from Na+ channel inactivation in dorsal root ganglion neurons, suggesting a mechanism for the sensory symptoms associated with the toxin (129). In animal experiments, P-CTX-1 can be detected in peripheral nerves within hours of exposure and persists for months; during this period, P-CTX-1 reduces the intrinsic growth capacity of peripheral neurons, which contributes to the delay in functional recovery (06). Carribean-CTX-1 (C-CTX-1) affects nerve excitability and neurotransmitter release at nerve terminals by inducing upregulation of Na+ channels and inhibition of K+ channels, at low nanomolar concentrations (88). CTX-1 is particularly effective at releasing calcitonin-gene related peptide (CGRP) from nerve terminals (134). In experimental studies in animals, P-CTX-1 reduced delta and theta electroencephalogram activity and disrupted the balance of excitatory and inhibitory neurotransmitters in the motor cortex (75). In a mouse model, persistence of P-CTX-1 in the nervous system induced an irreversible motor deficit that correlated with excitotoxicity and neurodegeneration detected in the motor cortical neurons (05). Maitotoxin acts on the calcium channel (59) and likely leads to a harmful calcium-dependent generation of intracellular reactive oxygen species (145). Gambierol blocks voltage-gated potassium channels (38). In addition, some ciguatoxins interfere with enzyme systems or have hemolytic effects (96; 142), and others have both cholinergic and adrenergic effects, including inhibitory effects on nicotinic receptors or stimulant effects on muscarinic receptors (51; 90; 94).

Significant slowing of sensory and motor nerve conduction velocities and F-wave latencies with prolongation of the absolute refractory and supernormal periods has been demonstrated in ciguatera poisoning (23; 24). This nerve conduction slowing could be a consequence of nodal swelling, increased internodal length, and increased nodal volume, all of which have been demonstrated with in vitro ciguatoxins (13; 86; 87).

The multiplicity of toxins and their varied actions on nerve, muscle, and the neuromuscular junction, with accompanying presynaptic and postsynaptic effects, account for the diverse clinical manifestations related to the intoxication. The toxins cross the blood-brain and placental barriers and can be secreted in breast milk and semen.

Ciguatoxins produce cold allodynia, without producing heat or mechanical allodynia, by activating sodium channels and producing a large peripheral sensitization to dynamic cold stimuli in thinly myelinated A delta (Aδ) fibers (47). In human experiments using intracutaneous injection of low millimolar concentrations of CTX, brain responses are much less to constant cooling than with dynamic temperature changes cerebellum. Brain areas that respond to dynamic cold stimuli during cold allodynia are located bilaterally and include the medial insula, medial cingulate cortex, secondary somatosensory cortex, frontal areas, and cerebellum. The same brain areas also responded to a dynamic warming stimulus on the control site, but remained silent to a dynamic warming stimulus on the injected site.

Ciguatera sensitization occurs when people previously intoxicated with ciguatoxin suffer a recurrence of typical ciguatera symptoms after ingesting fish that do not cause symptoms in ciguatoxin-naive individuals (17). The mechanisms underlying ciguatera sensitization remain undefined but apparently are not mediated by a channelopathy. Axonal excitability studies in patients with ciguatera sensitization found excitability parameters all within normal limits, arguing against dysfunction of axonal membrane ion channels in large-diameter fibers in ciguatera sensitization (138). Chronic ciguatera may involve serotonin metabolism with immune sensitization and delayed-type hypersensitivity (126). Inflammatory factors may also be important in chronic ciguatera. Pathologic activity of the complement/coagulation cascade has been demonstrated in patients with chronic ciguatera poisoning. In addition, gene expression profiling in brain, whole blood, and liver of mice exposed to CTX showed an acute antiinflammatory response in the brain, blood, and liver that was postulated to represent a systemic antiinflammatory environment to protect against cellular damage caused by the toxin (120).

Epidemiology

Ciguatera is endemic in a band-like area extending around the globe, generally from 35° North to 35° South latitude (89). Ciguatera poisoning is particularly common in certain areas of the Caribbean (especially the Virgin Islands and Puerto Rico) as well as in parts of southern Florida, Hawaii, Australia, and on several of the islands of the South Pacific, including the Marshalls, French Polynesia, American Samoa, Guam, and New Guinea. Cases have been reported from several states in the United States, the Mexican Pacific coast, Baja California, Canada, Japan, and, more recently, the Mediterranean. Some of this spread is due to the consumption of fish shipped in from endemic areas (111) or from travelers arriving home from endemic areas (104; 117; 72).

Ciguatera tends to be prevalent where there are recent blooms of algae that harbor the toxic dinoflagellates, which depend on a complex interaction of water temperature, disruption of underwater surfaces, and availability of nutrients. The highest rates of ciguatera fish poisoning in the Caribbean Sea and the West Indies between 1996 and 2006 were in the eastern Caribbean, where the water temperatures were highest and least variable (130). There also appears to be a temporal relationship in Hong Kong between the peak incidence of cholera outbreaks and ciguatera, which may be related to a common environmental trigger (76). Algae blooms may result from the availability of new surfaces produced by underwater explosions or recent construction of dams and seawalls. With the advent of dock construction, tourism, sewage outfall, global warming, and consequent coral bleaching, conditions favorable to G toxicus proliferation are increasing (80; 67). The eutrophication of marine environments (ie, excessive richness of nutrients in bodies of water, frequently due to runoff from the land) has also contributed to increasing levels of ciguatera; a study in Cuba found the level of organization of the local sport-fishing community and the degree of degradation of the local near-shore marine ecosystem to be key etiologic factors for the ciguatera outbreaks recorded in the 1990s (92).

Global warming has contributed to the emergence of dinoflagellate species in subtropical and temperate regions that had been limited to tropical areas (89; 131). This may lead to an increase in ciguatera prevalence and an expanded range of high-risk endemic areas, although to date there is little evidence that this has occurred (116; 131).

Globalization of the fishing industry and tourism have led to a progressive increase in the number of ciguatera cases (89). Ciguatera is the most common nonbacterial form of food poisoning related to seafood ingestion in the United States, Canada, and more recently, Europe (Centers for Disease Control 1982; 78; 127). Annually, between 50,000 and 500,000 people develop acute ciguatera poisoning from consuming toxic fish, and approximately 5% of these individuals develop chronic ciguatera, a multisystem, chronic illness that can last for decades (125; 89).

Risk factors for ciguatera toxicity include alcohol consumption at least weekly, a history of previous ciguatera episodes, lower levels of education, and frequent fish consumption (115). Risk factors for severe ciguatera include ingestion of reef fishes and CTX-rich fish parts, ingestion of high-risk fish (eg, barracuda), as well as concomitant alcohol consumption (114; 31; 116). Concomitant alcohol consumption is associated with a much higher risk of developing bradycardia, hypotension, and neuropathic sensory changes (33).

Ciguatera toxicity is underrecognized by medical providers, especially when patients present with ciguatera toxicity outside of endemic areas (109; 89; 73; 116).

Prevention

• Ciguatera can be prevented by not eating fish from tropical waters, specifically tropical reef fish.

• The main species responsible for poisoning include jack, snapper, grouper, barracuda, and goatfish.

• Ciguatera cannot be prevented by cooking or freezing contaminated fish.

Ciguatera can be prevented by not eating fish from tropical waters, and specifically tropical reef fish. The main species responsible for poisoning include jack, snapper, grouper, barracuda, and goatfish (20). Certain fish (including barracuda, grouper, hogfish, lion fish, and eels, among others) should never be eaten in endemic areas, and sale of these is often prohibited by law because of the recognized risk of toxicity (07; 28; 29; 32; 33; 50; 31; 44). The liver, other viscera, and roe of tropical fish may harbor high concentrations of ciguatoxins (62) and should be avoided in endemic areas. Because of the increased risk of severe symptoms, ingestion of CTX-rich fish parts with alcohol should be avoided (31). To prevent large outbreaks and severe illness, large apex predators from coral reefs should never be served at banquets (28; 33; 31).

Ciguatera cannot be prevented by cooking or freezing contaminated fish (73).

Several novel folkloric methods for detecting affected fish have been described.

In the Grand Caymans, local fishermen reportedly lay a fish down on the sand and if ants are attracted then the fish is considered safe to eat (70). Experienced fishermen from tropical areas reportedly rub their gums with fish organs, and if their gums tingle afterwards, then the fish is not safe to eat (25).

Differential diagnosis

Many other forms of food poisoning can mimic the initial gastrointestinal presentation of ciguatera, but most do not progress to involve other organ systems. In general, three classes of diseases can result from seafood consumption: allergies, infections, and intoxications (12). An allergic reaction, anisakiasis, results when people become sensitized to Anisakis (a genus of parasitic nematodes of fish and marine mammals), and then have an immunoglobulin E-mediated allergic reaction, including potentially anaphylaxis, after again eating fish infected with the organism (12). Scombroid is an intoxication due to ingestion of histamine that is formed when fish begins to decay; because histamine is also involved in allergic reactions, scombroid food poisoning resembles an allergic reaction and is often misidentified as a food allergy (12). Infections are usually self-limited and respond to supportive care, except for certain Vibrio species (46). The classic marine neurotoxic syndromes include the shellfish poisonings, puffer fish poisoning ("fugu") poisoning (due to tetrodotoxin-induced inhibition of voltage-gated sodium channels in nerve cell membranes), and ciguatera (04). The symptoms of ciguatera and neurotoxic shellfish poisoning are often similar.

Diagnostic workup

• The diagnosis of ciguatera is based on appropriate clinical manifestations, a high index of suspicion, and a specific history of reef fish ingestion.

• A case definition of ciguatera fish poisoning has been proposed.

• There are no specific laboratory abnormalities in humans related to ciguatera, and there is no clinically available test for the detection of ciguatoxins in human body fluids.

Ciguatera can be confused with many other illnesses (125). The diagnosis of ciguatera is based on appropriate clinical manifestations, a high index of suspicion, and a specific history of reef fish ingestion (11). Note that ciguatera poisoning can present anywhere in the world, from eating fish shipped from affected areas, or from travelers returning from trips to affected areas (102).

A case definition of ciguatera fish poisoning has been proposed (53):

Table 1. Case Definition of Ciguatera Fish Poisoning

Critical criteria:

Required features:

1. Patient consumed a saltwater (marine) fish that has been previously associated with ciguatera fish poisoning.*

2. Patient reports neurologic symptoms, which may include any combination and sequence of paresthesia, dysesthesia, pruritus, allodynia, myalgia, and dizziness.

3. Symptoms onset within 48 hours after eating the fish.

Consistent features:

1. Gastrointestinal symptoms (eg, nausea, vomiting, diarrhea) may precede or accompany the neurologic symptoms.

2. Gastrointestinal symptom onset is usually within minutes to 12 hours after fish consumption.

3. Cardiovascular symptoms and signs (eg, hypotension, bradycardia) may be present.

Laboratory criteria: Confirmation of ciguatoxin(s) in a remnant of the implicated raw or cooked fish meal.

Epidemiological criteria: Exposure to the same fish source as a confirmed ciguatera fish poisoning case.

Case classification:

1. Confirmed case: Any patient meeting the clinical and laboratory criteria.

2. Probable case: Any patient meeting the clinical and epidemiological criteria.

3. Possible case:

a. Any patient meeting the clinical criteria after consuming a saltwater (marine) fish that is either not previously associated with ciguatera fish poisoning or is of an unknown species.

b. Any patient with an illness presentation that differs slightly from the clinical criteria or is an unusual presentation that, in the judgment of the healthcare provider, merits consideration for a ciguatera fish poisoning diagnosis.

c. Any patient who meets the clinical criteria, but other etiologies have not been ruled out.

Outbreak definition: Two or more cases that are epidemiologically related.

*Note: Common ciguatoxic fish species include moray eel (Muraenidae), barracuda (Sphyraenidae), grouper (Serranidae), jacks (Carangidae), amberjack (Carangidae, g Seriola), snapper (Lutjanidae), surgeon fish (Acanthuridae), parrot fish (Scaridae), wrasses (Labridae), hogfish (Labridae, g Lachnolaimus), narrow barred mackerel (Scombridae, g Scomberomorus), Spanish mackerel (Scombridae, g Scomberomorus), trevally (Carangidae, g Caranx), and triggerfish (Balistidae). Other ciguatoxic fish are less commonly reported.

There are also no specific laboratory abnormalities in humans related to ciguatera, and there is no clinically available test for the detection of ciguatoxins in human body fluids, although the situation is under intense study (19; 18; 97; 58).

Multiple bioassay methods and several sophisticated immunochemical methods for detection of ciguatoxins in fish have been devised for research studies, but have not been widely employed in clinical medicine (65; 100; 144; 66; 82; 103; 112; 136; 48; 49; 83; 135; 101).

Reports of brain or spinal cord MRI findings in patients with ciguatera poisoning are limited (139; 84; 143). Wasay and colleagues reported a T2-hyperintense lesion in the cervical spinal cord (139), and Liang and colleagues reported similar MRI changes within the corpus callosum (84). Yalachkov and colleagues reported reversible intramyelinic cytotoxic edema symmetrically affecting distinct fiber tracts in 2 patients; in the more severely affected patient, there were marked diffusion-weighted imaging hyperintensities and apparent diffusion coefficient reductions throughout the corpus callosum, most pronounced in the splenium, as well as bilaterally in the pyramidal tract, ranging from the posterior portion of the internal capsule to the cerebral crus, and in the middle cerebellar peduncles (143).

Management

• Treatment is symptomatic and supportive.

• No known antidote exists.

• If vomiting has not occurred within 3 to 4 hours after ingestion, emetics or gastric lavage may be utilized to promote elimination of any remaining fish products and their associated toxins, though some discourage the use of emetics because they may exacerbate fluid losses.

• Activated charcoal combined with a nonmagnesium-containing cathartic in a slush can be administered to promote elimination of the toxin.

• Intravenous mannitol is considered the drug of choice for severe acute toxicity, especially within the first 24 hours, though this conclusion is not based on well-controlled studies.

• In severe poisoning, intravenous calcium gluconate (15 g/kg over 15 minutes, followed by a continuous infusion of 45 to 70 mg/kg until serum calcium is in midnormal range) has been recommended to counteract competitive inhibition of calcium by ciguatoxins.

Treatment is symptomatic and supportive; no known antidote exists (58). In severe intoxication, basic support measures should be initiated with monitoring of fluid and electrolytes, cardiac function, and blood gases, with awareness that severe bradycardia and respiratory paralysis may occur and that complications stemming from severe dehydration may rarely become life-threatening.

If vomiting has not occurred within three to four hours after ingestion, emetics or gastric lavage may be utilized to promote elimination of any remaining fish products and their associated toxins, though some discourage use of emetics because they may exacerbate fluid losses. Activated charcoal combined with a nonmagnesium-containing cathartic in a slush can be administered to promote elimination of the toxin.

Intravenous mannitol is considered the drug of choice for severe acute toxicity, especially within the first 24 hours, though this conclusion is not based on well-controlled studies (93). Nevertheless, dramatic effects have been reported when given early, rapidly, and in adequate quantities (1 g/kg of a 20% solution intravenously over one to two hours). Mannitol has been used effectively in both children and adults with severe initial presenting symptoms, including coma (99; 108; 141). Care must be taken to adequately hydrate the patient, who has often had severe diarrhea and vomiting, and to attend to fluid deficits prior to and during mannitol use, because of its potent osmotic diuretic action. Normal saline or Ringer lactate with additional electrolyte solutions should be used depending on vital signs, urine output, the amount of vomitus and diarrhea, and the results of laboratory studies.

Treatment with mannitol after the first 24 hours has had less dramatic results, and a double-blind study suggests that mannitol is not superior to normal saline in relieving symptoms and signs of ciguatoxin exposure at 24 hours and that mannitol has more side effects than normal saline (122). Nevertheless, one anecdotal report suggests potential benefit of mannitol treatment even a month after ciguatoxin exposure (123). Also, although the neuroprotective effect of mannitol in reducing the neurologic disturbances in ciguatera poisoning in people remains disputed, mannitol can reverse some toxic effects of ciguatoxin in vitro and in animal models (81; 113; 15).

Hypotension can usually be managed with volume replacement; pressor agents are rarely needed, but dopamine infusion (5 mg/kg per minute to 20 mg/kg per minute) can be used for severe and prolonged hypotension (34). Bradyarrhythmias usually respond well to atropine (0.01 to 0.02 mg/kg intravenously every 10 minutes for symptomatic heart rate less than 50 per minute), but transvenous cardiac pacing may be required in the presence of refractory bradycardia or heart block (34). Mechanical ventilatory support and oxygen may be needed in the event of respiratory failure.

In severe poisoning, intravenous calcium gluconate (15 g/kg over 15 minutes, followed by a continuous infusion of 45 to 70 mg/kg until serum calcium is in midnormal range), has been recommended to counteract competitive inhibition of calcium by ciguatoxins.

Certain additional medications may provide relief for individual symptoms. Benzodiazepines (eg, diazepam or lorazepam) and phenytoin have been helpful in treating associated convulsions. Indomethacin, ketorolac, and other nonsteroidal antiinflammatory agents are useful for dysesthesias, myalgias, arthralgias, and pruritus. Acetaminophen may be more effective than other analgesics for associated headaches. Corticosteroids are reportedly useful for arthralgias not responsive to other anti-inflammatory compounds. Gabapentin and lamotrigine may be helpful in patients with shooting pains, pruritus, dysesthesias, and cold allodynia (110; 147; 47). Amitriptyline may be helpful in ameliorating some ciguatera symptoms, including pruritus (21; 41; 22; 85). Fluoxetine may be helpful for treating associated chronic fatigue symptoms (14).

There are also anecdotal reports of the use of multiple other medications for symptom relief, including calcium-channel blockers, chlorpromazine, diphenhydramine, H2-receptor blockers, mexiletine, neostigmine, tramadol, vitamin B complex, vitamin B12, tocainide, and procaine, among others.

A “serotonin-sparing” diet eliminating fish or fish products, shellfish or shellfish products, nuts, coconuts, nut products, seeds, seed products (including oils), alcoholic beverages or ethanol-containing products, mayonnaise, chocolate, and mushrooms has also been recommended while a patient remains acutely intoxicated and for three to six months after symptoms resolve (126).

Anti-ciguatoxin monoclonal antibodies have been developed that exhibit neutralizing activity against ciguatoxins in vitro and in vivo (68). Such work is a first step toward a safe and rational method for in vivo detoxification of ciguatoxins.

Special considerations

Pregnancy

Although most pregnant women diagnosed as having ciguatera have been delivered at term with no apparent sequelae to the fetus, ciguatoxin apparently does cross the placental barrier, and may cause premature labor and spontaneous abortion (106; 10). Transmission of ciguatoxin from mother to infant via breast milk has also been reported, producing diarrheal illness in the infant (10; 16).

Anesthesia

An anecdotal report discusses implications in one case of uneventful anesthetic use without complications in a patient intoxicated six months previously, who had residual muscle pains and weakness prior to surgery (98).

Media

References

01
Anderson W. An account of some poisonous fish in the South Seas. In a letter to Sir John Pringle, Bart. P. R. S. from Mr. William Anderson, late surgeon's mate on board His Majesty's Ship the Resolution, now surgeon of that ship. Phil Trans R Soc Lond 1776;66:544-74.
02
Angibaud G, Rambaud S. Serious neurological manifestations of ciguatera: is the delay unusually long. J Neurol Neurosurg Psychiatry 1998;64(5):688-9. PMID 9598697
03
Armstrong P, Murray P, Nesdale A, Peckler B. Ciguatera fish poisoning. N Z Med J 2016;129(1444):111-14. PMID 27806035
04
Arvanitoyannis IS, Kotsanopoulos KV, Papadopoulou A. Rapid detection of chemical hazards (toxins, dioxins, and PCBs) in seafood. Crit Rev Food Sci Nutr 2014;54(11):1473-528. PMID 24580541
05
Asthana P, Zhang N, Kumar G, et al. Pacific ciguatoxin induces excitotoxicity and neurodegeneration in the motor cortex via caspase 3 activation: implication for irreversible motor deficit. Mol Neurobiol 2018;55(8):6769-87. PMID 29349574
06
Au NP, Kumar G, Asthana P, et al. Ciguatoxin reduces regenerative capacity of axotomized peripheral neurons and delays functional recovery in pre-exposed mice after peripheral nerve injury. Sci Rep 2016;6:26809 PMID 27229176
07
Azziz-Baumgartner E, Luber G, Conklin L, et al. Assessing the incidence of ciguatera fish poisoning with two surveys conducted in Culebra, Puerto Rico, during 2005 and 2006. Environ Health Perspect 2012;120(4):526-9. PMID 22275728
08
Bagnis R, Chanteau S, Chungue E. Origins of ciguatera fish poisoning: a new dinoflagellate, Gambierdiscus toxicus, Adachi and Fukuyo, definitely involved as a causal agent. Toxicon 1980;18:199-208. PMID 7190330
09
Bagnis R, Kiberski T, Lauguer S. Clinical observation on 3009 cases of ciguatera (fish poisoning) in the South Pacific. Am J Trop Med Hyg 1979;28:1067-73. PMID 574366
10
Bagnis RA, Legrand AM. Clinical features on 12,890 cases of ciguatera (fish poisoning) in French Polynesia. In: Gopalakrishnkone P, Tan CK, editors. Progress in venom and toxin research. Proceedings of the First Asia-Pacific Congress on Animal, Plant and Microbial. Toxins: Singapore, 1987:372-84.
11
Bailey S, Withers T. Ciguatera poisoning in the Cook Islands. BMJ Case Rep 2014;2014. PMID 24966268
12
Banks TA, Gada SM. Cross-reactivity and masqueraders in seafood reactions. Allergy Asthma Proc 2013;34(6):497-503. PMID 24169056
13
Benoit E, Juzans P, Legrand AM, et al. Nodal swelling produced by ciguatoxin-induced selective activation of sodium channels in myelinated nerve fibers. Neuroscience 1996;71:1121-31. PMID 8684616
14
Berlin RM, King SL, Blythe DG. Symptomatic improvement of chronic fatigue with fluoxetine in ciguatera fish poisoning. Med J Aust 1992;157:567. PMID 1479984
15
Birinyi-Strachan LC, Davies MJ, Lewis RJ, Nicholson GM. Neuroprotectant effects of iso-osmolar D-mannitol to prevent Pacific ciguatoxin-1 induced alterations in neuronal excitability: a comparison with other osmotic agents and free radical scavengers. Neuropharmacology 2005;49(5):669-86. PMID 15950247
16
Blythe DG, de Sylva DP. Mother's milk turns toxic following fish feast. JAMA 1990;264:2074. PMID 2214071
17
Bottein Dechraoui MY, Rezvani AH, Gordon CJ, Levin ED, Ramsdell JS. Repeat exposure to ciguatoxin leads to enhanced and sustained thermoregulatory, pain threshold and motor activity responses in mice: relationship to blood ciguatoxin concentrations. Toxicology 2008;246(1):55-62. PMID 18280027
18
Bottein Dechraoui MY, Wang Z, Ramsdell JS. Optimization of ciguatoxin extraction method from blood for Pacific ciguatoxin (P-CTX-1). Toxicon 2007;49(1):100-5. PMID 17113119
19
Bottein Dechraoui MY, Wang Z, Turquet J, et al. Biomonitoring of ciguatoxin exposure in mice using blood collection cards. Toxicon 2005;46(3):243-51. PMID 15979117
20
Boucaud-Maitre D, Vernoux JP, Pelczar S, et al. Incidence and clinical characteristics of ciguatera fish poisoning in Guadeloupe (French West Indies) between 2013 and 2016: a retrospective cases-series. Sci Rep 2018;8(1):3095. PMID 29449664
21
Bowman P. Amitriptyline and ciguatera. Med J Aust 1984;143:802. PMID 6727763
22
Calvert GM, Hryhorczuk DO, Leikin JB. Treatment of ciguatera fish poisoning with amitriptyline and nifedipine. J Toxicol Clin Toxicol 1987;25:423-8. PMID 3430658
23
Cameron J, Flowers AE, Capra MF. Effects of ciguatoxin on nerve excitability in rats (Part I). J Neurol Sci 1991a;101:87-92. PMID 2027032
24
Cameron J, Flowers AE, Capra MF. Electrophysiological studies on ciguatera poisoning in man (Part II). J Neurol Sci 1991b;101:93-7. PMID 2027033
25
Caplan CE. Ciguatera fish poisoning. CMAJ 1998;159:1394. PMID 9861212
26
Centers for Disease Control. Fish borne diseases outbreaks: annual summary 1982. Atlanta, 1985.
27
Centers for Disease Control and Prevention (CDC). Cluster of ciguatera fish poisoning--North Carolina, 2007. MMWR Morb Mortal Wkly Rep 2009; 58(11):283-5. PMID 19325530
28
Centers for Disease Control and Prevention (CDC). Ciguatera fish poisoning - New York City, 2010-2011. MMWR Morb Mortal Wkly Rep 2013;62(4):61-5. PMID 23364271
29
Chan TY. Ciguatera caused by consumption of humphead wrasse. Toxicon 2013b;76:255-9. PMID 24141055
30
Chan TY. Ciguatera fish poisoning in East Asia and southeast Asia. Mar Drugs 2015b;13(6):3466-78. PMID 26042615
31
Chan TY. Emergence and epidemiology of ciguatera in the coastal cities of southern China. Mar Drugs 2015a;13(3):1175-84. PMID 25738329
32
Chan TY. Epidemiology and clinical features of ciguatera fish poisoning in Hong Kong. Toxins (Basel) 2014a;6(10):2989-97. PMID 25333356
33
Chan TY. Large outbreaks of ciguatera after consumption of brown marbled grouper. Toxins (Basel) 2014b;6(7):2041-9. PMID 25019942
34
Chan TY. Severe bradycardia and prolonged hypotension in ciguatera. Singapore Med J 2013a;54(6):e120-2. PMID 23665698
35
Chateau-Degat ML, Beuter A, Vauterin G, et al. Neurologic signs of ciguatera disease: evidence of their persistence. Am J Trop Med Hyg 2007;77(6):1170-5. PMID 18165542
36
Cook J. A voyage towards the South Pole and round the world. London, England: Strahan & Cadell, 1777:39-40, 112-3.
37
Copeland NK, Palmer WR, Bienfang PK. Ciguatera fish poisoning in Hawai'i and the Pacific. Hawaii J Med Public Health 2014;73(11 Suppl 2):24-7. PMID 25478299
38
Cuypers E, Abdel-Mottaleb Y, Kopljar I, et al. Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels. Toxicon 2008;51(6):974-83. PMID 18313714
39
Darius HT, Roue M, Sibat M, et al Toxicological investigations on the sea urchin tripneustes gratilla (toxopneustidae, echinoid) from anaho bay (Nuku Hiva, French Polynesia): evidence for the presence of Pacific ciguatoxins. Mar Drugs 2018;16(4). PMID 29642418
40
Darius HT, Roue M, Sibat M, et al. Tectus niloticus (tegulidae, gastropod) as a novel vector of ciguatera poisoning: detection of pacific ciguatoxins in toxic samples from Nuku Hiva Island (French Polynesia). Toxins (Basel). Toxins (Basel) 2017;10(1):pii:E2. PMID 29267222
41
Davis RT, Villar LA. Symptomatic improvement with amitriptyline in ciguatera fish poisoning. N Engl J Med 1986;315:65. PMID 3713788
42
Dechraoui MY, Naar J, Pauillac S, Legrand AM. Ciguatoxins and brevetoxins, neurotoxic polyether compounds active on sodium channels. Toxicon 1999;37:125-43. PMID 9920485
43
Derian A, Khurana S, Rothenberg J, Plumlee C. Intractable seizures and rehabilitation in ciguatera poisoning. Am J Phys Med Rehabil 2017;96(5):e89-e92. PMID 27584136
44
Díaz-Asencio L, Clausing RJ, Vandersea M, et al. Ciguatoxin occurrence in food-web components of a Cuban coral reef ecosystem: risk-assessment implications. Toxins (Basel) 2019;11(12):722. PMID 31835676
45
DiNubile MJ, Hokama Y. The ciguatera poisoning syndrome from farm-raised salmon. Ann Intern Med 1995;122:113-4. PMID 7992985
46
Eastaugh J, Shepherd S. Infections and toxic syndromes from fish and shellfish consumption. Arch Intern Med 1989;149:1735-40. PMID 2669661
47
Eisenblatter A, Lewis R, Dörfler A, Forster C, Zimmermann K. Brain mechanisms of abnormal temperature perception in cold allodynia induced by ciguatoxin. Ann Neurol 2017;81(1):104-16. PMID 27997033
48
Empey Campora C, Dierking J, Tamaru CS, Hokama Y, Vincent D. Detection of ciguatoxin in fish tissue using sandwich ELISA and neuroblastoma cell bioassay. J Clin Lab Anal 2008a;22(4):246-53. PMID 18623134
49
Empey Campora C, Hokama Y, Yabusaki K, Isobe M. Development of an enzyme-linked immunosorbent assay for the detection of ciguatoxin in fish tissue using chicken immunoglobulin Y. J Clin Lab Anal 2008b;22(4):239-45. PMID 18623134
50
Epelboin L, Pérignon A, Hossen V, Vincent R, Krys S, Caumes E. Two clusters of ciguatera fish poisoning in Paris, France, related to tropical fish imported from the French Caribbean by travelers. J Travel Med 2014;21(6):397-402. PMID 25345983
51
Escalona de Motta G, Mercado JA, Tosteson TR, Ballantine DL. Inhibition of skeletal muscle response to acetylcholine by dinoflagellate and ciguatoxic fish extracts. In: Tosteson TR, editor. Ciguatera: proceedings of the Third International Conference. Quebec: Polyscience, 1992:79-88.
52
Friedman MA, Arena P, Levin B, et al. Neuropsychological study of ciguatera fish poisoning: a longitudinal case-control study. Arch Clin Neuropsychol 2007;22(4):545-53. PMID 17482422
53
Friedman MA, Fernandez M, Backer LC, Dickey RW, et al. An updated review of ciguatera fish poisoning: clinical, epidemiological, environmental, and public health management. Mar Drugs 2017;15(3). PMID 28335428
54
Gaboriau M, Ponton D, Darius HT, Chinain M. Ciguatera fish toxicity in French Polynesia: size does not always matter. Toxicon 2014;84:41-50. PMID 24699216
55
Gatti C, Oelher E, Legrand AM. Severe seafood poisoning in French Polynesia: a retrospective analysis of 129 medical files. Toxicon 2008;51(5):746-53. PMID 18207482
56
Gatti CM, Lonati D, Darius HT, et al. Tectus niloticus (tegulidae, gastropod) as a novel vector of ciguatera poisoning: clinical characterization and follow-up of a mass poisoning event in Nuku Hiva Island (French Polynesia). Toxins (Basel) 2018;10(3):pii:E102. PMID 29495579
57
Glaizal ML,Tichadou L, Drouet G, Hayek-Lanthois M, De Haro L. Ciguatera contracted by French tourists in Mauritius recurs in Senegal. Clin Toxicol (Phila) 2011; 49(8):767. PMID 21867366
58
Grattan LM, Holobaugh S, Morris JG Jr. Harmful algal blooms and public health. Harmful Algae 2016;57(B):2-8. PMID 27616971
59
Gutmann L, Gutmann L. Axonal channelopathies: an evolving concept in the pathogenesis of peripheral nerve disorders. Neurology 1996;47(1):18-21. PMID 8710074
60
Halstead BW. Poisonous and venomous marine animals of the world. Princeton, NJ: Darwin Pr, 1978.
61
Hamburger HA. The neuro-ophthalmologic signs of ciguatera poisoning, a case report. Ann Ophthalmol 1986;18(10):287-8. PMID 3777754
62
Hamilton B, Whittle N, Shaw G, Eaglesham G, Moore MR, Lewis RJ. Human fatality associated with Pacific ciguatoxin contaminated fish. Toxicon 2010;56(5):668-73. PMID 19538985
63
Heir GM. Ciguatera neurotoxin poisoning mimicking burning mouth syndrome. Quintessence Int 2005;36(7-8):547-50. PMID 15997935
64
Hogg RC, Lewis RJ, Adams DJ. Ciguatoxin (CTX-1) modulates single tetrodotoxin-sensitive sodium channels in rat parasympathetic neurones. Neurosci Lett 1998;252:103-6. PMID 9756332
65
Hokama Y, Asahina AY, Shang ES, Hong TW, Shirai JL. Evaluation of the Hawaiian reef fishes with the solid phase immunobead assay. J Clin Lab Anal 1993;7(1):26-30. PMID 8426271
66
Hokama Y, Takenaka WE, Nishimura KL, Ebesu JS, Bourke R, Sullivan PK. A simple membrane immunobead assay for detecting ciguatoxin and related polyethers from human ciguatera intoxication and natural reef fishes. J AOAC Int 1998;81(4):727-35. PMID 9680697
67
Hokama Y, Wachi KM, Shiraki A, Goo C, Ebesu JS. The biological assessment of flora and fauna as standards for changes in the near-shore ocean environment: a study of Barbers Point Harbor. J Nat Toxins 2001;10:57-68. PMID 11288729
68
Inoue M, Lee N, Tsumuraya T, Fujii I, Hirama M. Use of monoclonal antibodies as an effective strategy for treatment of ciguatera poisoning. Toxicon 2009;53(7-8): 802-5. PMID 19254735
69
Inserra MC, Israel MR, Caldwell A, et al. Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1. Sci Rep 2017;7:42810. PMID 28225079
70
Irving AM. Ciguatera fish poisoning (letter). CMAJ 1999;160:1127. PMID 10234338
71
Isbister GK, Kiernan MC. Neurotoxic marine poisoning. Lancet Neurol 2005;4(4):219-28. PMID 15778101
72
Juranovic LR, Park DL. Foodborne toxins of marine origin: ciguatera. In: Reviews of environmental contamination and toxicology. New York: Springer-Verlag, 1991:51-94.
73
Klekamp BG, Bodager D, Matthews SD. Use of surveillance systems in detection of a ciguatera fish poisoning outbreak - Orange County, Florida, 2014. MMWR Morb Mortal Wkly Rep 2015;64(40):1142-4. PMID 26468736
74
Kodama AM, Hokama Y, Yasumoto T, Fukui M, Manea SJ, Sutherland N. Clinical and laboratory findings implicating palytoxin as cause of ciguatera poisoning due to Decapterus macrosoma (mackerel). Toxicon 1989;27(9):1051-3. PMID 2572075
75
Kumar G, Au NPB, Lei ENY, et al. Acute exposure to Pacific ciguatoxin reduces electroencephalogram activity and disrupts neurotransmitter metabolic pathways in motor cortex. Mol Neurobiol 2017;54(7):5590-603. PMID 27613284
76
Kwan LC, Cheung DK, Kam KM. Peak occurrences of ciguatera fish poisoning precede cholera outbreaks in Hong Kong. Epidemiol Infect 2003;131(1):621-6. PMID 12948360
77
Lange WR. Ciguatera fish poisoning. Am Fam Physician 1994;50(3):579-84. PMID 8067324
78
Lange WR. Ciguatera toxicity. Am Fam Physician 1987;35:177-82. PMID 3565219
79
Lange WR, Lipkin KM, Yang GC. Can ciguatera be a sexually transmitted disease. [abstract]. J Toxicol Clin Toxicol 1989;27(3):193-7. PMID 2810444
80
Lehane L. Ciguatera update. Med J Austr 2000;172:176-9. PMID 10772591
81
Lewis RJ. Mannitol reverses the action of ciguatoxin in vitro. Proc Austr Physio Pharmacol Soc 1988;19:237.
82
Lewis RJ, Jones A, Vernoux JP. HPLC/tandem electrospray mass spectrometry for the determination of sub-ppb levels of pacific and Caribbean ciguatoxins in crude extracts of fish. Anal Chem 1999;71:247-50. PMID 9921131
83
Lewis RJ, Yang A, Jones A. Rapid extraction combined with LC-tandem mass spectrometry (CREM-LC/MS/MS) for the determination of ciguatoxins in ciguateric fish flesh. Toxicon 2009;54(1):62-6. PMID 19303895
84
Liang CK, Lo YK, Li JY, Lai PH. Neurological picture: reversible corpus callosum lesion in ciguatera poisoning. J Neurol Neurosurg Psychiatry 2009;80:587-8. PMID 19448089
85
Lipkin KM. Ciguatera presenting as psychiatric disorder. Arch Gen Psychiatry 1989;46:348-85. PMID 2930337
86
Mattei C, Benoit E, Juzans P, Legrand AM, Molgo J. Gambiertoxin (CTX-4B), purified from wild Gambierdiscus toxicus dinoflagellates, induces Na(+)-dependent swelling of single frog myelinated axons and motor nerve terminals in situ. Neurosci Lett 1997;234(2-3):75-8. PMID 9364501
87
Mattei C, Dechraoui MY, Molgo J, Meunier FA, Legrand AM, Benoit E. Neurotoxins targeting receptor site 5 of voltage-dependent sodium channels increase the nodal volume of myelinated axons. J Neurosci Res 1999;55:666-73. PMID 10220108
88
Mattei C, Marquais M, Schlumberger S, et al. Analysis of Caribbean ciguatoxin-1 effects on frog myelinated axons and the neuromuscular junction. Toxicon 2010;56(5):759-67. PMID 19646468
89
Mattei C, Vetter I, Eisenblätter A, et al. Ciguatera fish poisoning: a first epidemic in Germany highlights an increasing risk for European countries. Toxicon 2014;91:76-83. PMID 25448771
90
Mercado JA, Escalona de Motta G, Silva W, Tosteson T, Blanco R. Toxic extracts from the benthic dinoflagellate O. lenticularis bind to rat brain muscarinic receptor. Society for Neuroscience Abstracts 1992;18(2).
91
Morris JG, Lewin P, Hargrett NT. Clinical features of ciguatera fish poisoning. Arch Intern Med 1982;142:1090-2. PMID 7201299
92
Morrison K, Aguiar Prieto P, Castro Dominguez A, Waltner-Toews D, Fitzgibbon J. Ciguatera fish poisoning in la Habana, Cuba: a study of local social-ecological resilience. Ecohealth 2008;5(3):346-59. PMID 18716840
93
Mullins ME, Hoffman RS. Is mannitol the treatment of choice for patients with ciguatera fish poisoning? Clin Toxicol (Phila) 2017;55(9):947-55. PMID 28535116
94
Nguyen-Huu TD, Mattei C, Wen PJ, et al. Ciguatoxin-induced catecholamine secretion in bovine chromaffin cells: mechanism of action and reversible inhibition by brevenal. Toxicon 2010;56(5):792-6. PMID 19682481
95
Oh SY, Kim DH, Seo MW, Shin BS. Reversible cerebellar dysfunction associated with ciguatera fish poisoning. J Emerg Med 2012;43(4):674-6. PMID 22325556
96
Ohizumi Y. Pharmacological actions of the marine toxins ciguatoxin and maitotoxin isolated from poisonous fish. Biol Bull 1987;172:132-6.
97
Okumura M, Tsuzuki H, Tomita B. A rapid detection method for paralytic shellfish poisoning toxins by cell bioassay. Toxicon 2005;46(1):93-8. PMID 15922387
98
Ortega RA, Singh N, Peine R. Ciguatera and the anesthesiologist [letter]. Can J Anesth 1996;43:1080. PMID 9011406
99
Palafox N, Jain L, Pinano A, Gulick T, Williams R, Schatz I. Successful treatment of ciguatera fish poisoning with intravenous mannitol. JAMA 1988;759:2740-2. PMID 3128666
100
Park DL. Evolution of methods for assessing ciguatera toxins in fish. Rev Environ Contam Toxicol 1994;136:1-20. PMID 8029489
101
Pasinszki T, Lako J, Dennis TE. Advances in detecting ciguatoxins in fish. Toxins (Basel) 2020;12(8):494. PMID 32752046
102
Patel M, Jutzy K. A curious case of ciguatera fish poisoning in the Midwest and a review for clinicians. J Emerg Med 2020;58(3):e109-11. PMID 31866166
103
Pauillac S, Sasaki M, Inoue M, et al. Characterization of mice antisera elicited with a ciguatoxin tetracyclic synthetic ring fragment (JKLM) conjugated to carrier proteins. Toxicon 2000;38:669-85. PMID 10673159
104
Payne CA, Payne SN. Ciguatera in Puerto Rico and the Virgin Islands. N Engl J Med 1977;296:949-50. PMID 557726
105
Payne CA, Payne SN, McGinnis SP. Ciguatera and the neurologist. Neurology 1988;38(Suppl 1):308.
106
Pearn J, Harvey P, De Ambrosis W, Lewis R, McKay R. Ciguatera and pregnancy. Med J Aust 1982;1:57-8. PMID 7070322
107
Pearn JH. One organic cause of the chronic fatigue syndrome. J Chronic Fatig Synd 1996;22:29-34.
108
Pearn JH, Lewis RK, Fuff T. Ciguatera and mannitol: experience with a new treatment regimen. Med J Aust 1989;151:77-80. PMID 2500582
109
Pennotti R, Scallan E, Backer L, Thomas J, Angulo FJ. Ciguatera and scombroid fish poisoning in the United States. Foodborne Pathog Dis 2013;10(12):1059-66. PMID 24093307
110
Perez CM, Vasquez PA, Perret CF. Treatment of ciguatera poisoning with gabapentin. N Engl J Med 2001;344:692-3. PMID 11229348
111
Pilon P, Dion R, Jochem K, et al. Ciguatera food poisoning linked to the consumption of imported barracuda--Montreal, Quebec, 1998. Can Commun Dis Rep 2000;26:73-6. PMID 10893819
112
Pottier I, Vernoux JP, Jones A, Lewis RJ. Analysis of toxin profiles in three different fish species causing ciguatera fish poisoning in Guadeloupe, French West Indies. Food Add Contam 2002;19:1034-42. PMID 12456274
113
Purcell CE, Capra MF, Cameron J. Action of mannitol in ciguatoxin-intoxicated rats. Toxicon 1999;37:67-76. PMID 9920481
114
Radke EG, Grattan LM, Cook RL, Smith TB, Anderson DM, Morris JG Jr. Ciguatera incidence in the US Virgin Islands has not increased over a 30-year time period despite rising seawater temperatures. Am J Trop Med Hyg 2013a;88(5):908-13. PMID 23400575
115
Radke EG, Grattan LM, Morris JG. Association of cardiac disease and alcohol use with the development of severe ciguatera. South Med J 2013b;106(12):655-7. PMID 24305521
116
Radke EG, Reich A, Morris JG Jr. Epidemiology of Ciguatera in Florida. Am J Trop Med Hyg 2015;93(2):425-32. PMID 26123957
117
Raikhlin-Eisenkraft B, Finkelstein Y, Spanier E. Ciguatera-like poisoning in the Mediterranean. Vet Hum Toxicol 1988;30(6):582-3. PMID 3245127
118
Robertson A, Garcia AC, Quintana HA, et al. Invasive lionfish (Pterois volitans): a potential human health threat for ciguatera fish poisoning in tropical waters. Mar Drugs 2013;12(1):88-97. PMID 24378919
119
Rossini GP, Hess P. Phycotoxins: chemistry, mechanisms of action and shellfish poisoning. EXS 2010;100:65-122. PMID 20358682
120
Ryan JC, Morey JS, Bottein MY, Ramsdell JS, Van Dolah FM. Gene expression profiling in brain of mice exposed to the marine neurotoxin ciguatoxin reveals an acute anti-inflammatory, neuroprotective response. BMC Neurosci 2010;11:107. PMID 20796285
121
Schlaich C, Hagelstein JG, Burchard GD, Schmiedel S. Outbreak of ciguatera fish poisoning on a cargo ship in the port of hamburg. J Travel Med 2012;19(4):238-42. PMID 22776385
122
Schnorf H, Taurarii M, Cundy T. Ciguatera fish poisoning. A double-blind randomized trial of mannitol therapy. Neurology 2002;58:873-80. PMID 11914401
123
Schwarz ES, Mullins ME, Brooks CB. Ciguatera poisoning successfully treated with delayed mannitol. Ann Emerg Med 2008;52(4):476-7. PMID 18809112
124
Senthilkumaran SN, Balamurgan N, Suresh P, Thirumalaikolundusubramanian P. Painful ejaculation. Something fishy. Saudi Med J 2010;31(4):451-2. PMID 20383428
125
Shoemaker RC, House D, Ryan JC. Defining the neurotoxin derived illness chronic ciguatera using markers of chronic systemic inflammatory disturbances: a case/control study. Neurotoxicol Teratol 2010;32(6):633-9. PMID 20685390
126
Sims JK. A theoretical discourse on the pharmacology of toxic marine ingestions. Ann Emerg Med 1987;16:1006-15. PMID 3307551
127
Skinner MP, Brewer TD, Johnstone R, Fleming LE, Lewis RJ. Ciguatera fish poisoning in the Pacific Islands (1998 to 2008). PLoS Negl Trop Dis 2011;5(12):e1416. PMID 22180797
128
Soliño L, Widgy S, Pautonnier A, Turquet J, et al. Prevalence of ciguatoxins in lionfish (Pterois spp.) from Guadeloupe, Saint Martin, and Saint Barthélmy Islands (Caribbean). Toxicon 2015;102:62-8. PMID 26026621
129
Strachan LC, Lewis RJ, Nicholson GM. Differential actions of pacific ciguatoxin-1 on sodium channel subtypes in mammalian sensory neurons. J Pharmacol Exp Ther 1999;288:379-88. PMID 9862792
130
Tester PA, Feldman RL, Nau AW, Kibler SR, Wayne Litaker R. Ciguatera fish poisoning and sea surface temperatures in the Caribbean Sea and the West Indies. Toxicon 2010;56(5):698-710. PMID 20206196
131
Tester PA, Litaker RW, Berdalet E. Climate change and harmful benthic microalgae. Harmful Algae 2020;91:101655. PMID 32057343
132
Tosteson TR. The diversity and origins of toxins in ciguatera fish poisoning. PR Health Sci J 1995;14(2):117-29. PMID 7617831
133
Tosteson TR, Ballantine DL, Tosteson CG, et al. Comparative toxicity of Gambierdiscus toxicus, Ostreopsis lenticularis, and associated microflora. Mar Fish Rev 1986;48:57-9.
134
Touska F, Sattler S, Malsch P, Lewis RJ, Reeh PW, Zimmermann K. Ciguatoxins evoke potent CGRP release by activation of voltage-gated sodium channel subtypes Na(V)1.9, Na(V)1.7 and Na(V)1.1. Mar Drugs 2017;15(9). PMID 28867800
135
Tsumuraya T, Fujii I, Hirama M. Production of monoclonal antibodies for sandwich immunoassay detection of Pacific ciguatoxins. Toxicon 2010;56(5):797-803. PMID 19523973
136
Tsumuraya T, Fuiji I, Inoue M, Tatami A, Miyazaki K, Hirama M. Production of monoclonal antibodies for sandwich immunoassay detection of ciguatoxin 51-hydroxyCTX3C. Toxicon 2006;48(3):287-94. PMID 16890263
137
Vernoux JP, Lewis JL. Isolation and characterization of Caribbean ciguatoxins from the horse-eye jack (Caranx latus). Toxicon 1997;35:889-900. PMID 9241783
138
Vucic S, Kiernan MC. Normal axonal ion channel function in large peripheral nerve fibers following chronic ciguatera sensitization. Muscle Nerve 2008;37(3):403-5. PMID 17941032
139
Wasay M, Sarangzai A, Siddiqi A, Nizami Q. Ciguatera fish poisoning with elevated muscle enzymes and abnormal spinal MRI. Southeast Asian J Trop Med Public Health 2008;39(2):307-9. PMID 18564718
140
Williams EH Jr, Bunkley-Williams L, Tosteson TR. Hysterical symptoms of ciguatera fish poisoning: a possible explanation for some of the complex and varied symptomology. Psychosom Med 2008;70(3):384-5. PMID 18378861
141
Williams RK, Palafox NA. Treatment of pediatric ciguatera fish poisoning. Am J Dis Child 1990;144:747-8. PMID 2113348
142
Wu CH, Narahashi T. Mechanism of action of novel marine neurotoxins on ion channels. Annu Rev Pharmacol Toxicol 1988;28:141-61. PMID 2454608
143
Yalachkov Y, Hildner M, Polomac N, Jahnke K, Wagner M, Baudrexel S. Cytotoxic edema affecting distinct fiber tracts in ciguatera fish poisoning. Neurology 2019;92(3):145-7. PMID 30578371
144
Yasumoto T, Satake M. Chemistry, etiology and determination methods of ciguatera toxins. J Toxicol -Toxin Reviews 1996;15:91-107.
145
Yi SJ, Kim KH, Choi HJ, et al. [Ca(2+)]-dependent generation of intracellular reactive oxygen species mediates maitotoxin-induced cellular responses in human umbilical vein endothelial cells. Mol Cells 2006;21(1):121-8. PMID 16511354
146
Yosipovitch G, Yarnitsky D, Mermelstein V, et al. Paradoxical heat sensation in uremic polyneuropathy. Muscle Nerve 1995;18:768-71. PMID 7783767
147
Zimmermann K, Deuis JR, Inserra MC, Collins LS, et al. Analgesic treatment of ciguatoxin-induced cold allodynia. Pain 2013;154(10):1999-2006. PMID 23778293

Contributors

Author

  • Apdl

    Douglas J Lanska MD FAAN MS MSPH

    Dr. Lanska of the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and IM Sechenov First Moscow State Medical University has no relevant financial relationships to disclose.

    See Profile

Former Authors

  • Charles Payne MD and Sylvia N Payne MD (original authors), and Elijah W Stommel MD

Patient Profile

Age range of presentation
  • 0 month to 65+ years
Sex preponderance
  • male=female
Heredity
  • none
Population groups selectively affected
  • none selectively affected
Occupation groups selectively affected
  • none selectively affected

ICD & OMIM codes

ICD-9
  • Toxic effect of fish and shellfish eaten as food: 988.0
ICD-10
  • Ciguatera fish poisoning: T61.0

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com